HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

3D culture boosting fullerenol nanoparticles to induce calreticulin exposure on MCF-7 cells for enhanced macrophage-mediated cell removal.

Abstract
Calreticulin (CRT) on the cell surface that acts as an "eat me" signal is vital for macrophage-mediated programmed cell removal. The polyhydroxylated fullerenol nanoparticle (FNP) has appeared as an effective inducer to cause CRT exposure on cancer cell surface, but it failed in treating some cancer cells such as MCF-7 cells based on previous findings. Here, we carried out the 3D culture of MCF-7 cells, and interestingly found that the FNP induced CRT exposure on cells in 3D spheres via re-distributing CRT from endoplasmic reticulum (ER) to cell surface. Phagocytosis experiments in vitro and in vivo illustrated the combination of FNP and anti-CD47 monoclonal antibody (mAb) further enhanced macrophage-mediated phagocytosis to cancer cells. The maximal phagocytic index in vivo was about three times higher than that of the control group. Moreover, in vivo tumorigenesis experiments in mice proved that FNP could regulate the progress of MCF-7 cancer stem-like cells (CSCs). These findings expand the application of FNP in tumor therapy of anti-CD47 mAb and 3D culture can be used as a screening tool for nanomedicine.
AuthorsSen Liu, Haojun Liang, Linwen Lv, Fan Hu, Qiuyang Liu, Yujiao Wang, Junyu Zhu, Ziteng Chen, Jiacheng Li, Zhijie Wang, Ya-Nan Chang, Juan Li, Xiancai Ma, Kui Chen, Gengmei Xing
JournalColloids and surfaces. B, Biointerfaces (Colloids Surf B Biointerfaces) Vol. 224 Pg. 113204 (Apr 2023) ISSN: 1873-4367 [Electronic] Netherlands
PMID36801743 (Publication Type: Journal Article)
CopyrightCopyright © 2023 Elsevier B.V. All rights reserved.
Chemical References
  • fullerenol
  • Calreticulin
  • Antineoplastic Agents
Topics
  • Humans
  • Mice
  • Animals
  • MCF-7 Cells
  • Calreticulin (metabolism)
  • Macrophages (metabolism)
  • Phagocytosis
  • Antineoplastic Agents (pharmacology)
  • Nanoparticles

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: